Bull78

[Bull78 @gideonpISR]

@GenExDividend Do you know who are the bankers?

[Bull78 @gideonpISR]

@MoSalah What about my people that your Naziz friends slater? Play football and shut your mouth

[Bull78 @gideonpISR]

#StandWithIsrael #Israel

[Bull78 @gideonpISR]

#NewProfilePic

[Bull78 @gideonpISR]

#StandsWithIsrael #Israel

https://t.co/jCsSbTctKB

[Mohammad Kabiya @mohammadkabiya]

ارهابيي حماس دخلوا اسرائيل كقطعان الدواعش لذبح الاطفال، النساء والشيوخ الاسرائليين.

מחבלי חמאס נכנסו לישראל כמו עדרים של דאעש כדי לשחוט תינוקות, נשים וזקנים ישראלים.

Hamas terrorists entered Israel like ISIS herds to slaughter Israeli babies, women and elders.

[Bull78 @gideonpISR]

@BayAreaBiotechI If you compare to Ph3 not to if you compare to P2.

[Bull78 @gideonpISR]

@TrumX3 Unbelievable

[Bull78 @gideonpISR]

$KZR- 261...the Company now expects to report safety and dose escalation data and to initiate the dose expansion portion of the trial in 2024 and plans to report topline data from the expansion portion of the trial when available... !

[Bull78 @gideonpISR]

@Biotech_AI It is the second time that there has been a delay…I am worried about the execution capabilities of this company
Science is good though

[Bull78 @gideonpISR]

$KZR Delayed 261 to 24…it is open label…not good…

[Bull78 @gideonpISR]

@gurgavin Because the app is not good

[Bull78 @gideonpISR]

$CRNX In my opinion, the comparison to Micapssa is wrong; the comparison should be to other exogenous Sst... the POC that the company has shown so far doest make me feel comfortable that the results will be good enough to cause Doctors to stop giving SOC that work.

[Bull78 @gideonpISR]

$ZURA
A combo of BAFF and IL17 makes sence...too early...

[Bull78 @gideonpISR]

$VTYX
There is no correlation between ALC and Efficacy
There is no correlation between IC coverage and PASI...

[Bull78 @gideonpISR]

@Here_4_Sports $KNSA -How strong this patent? The composition of matter patent is expired..it worries me

[Bull78 @gideonpISR]

Is $BCYC down because 24% neuropathy?

[Bull78 @gideonpISR]

@ohadhammer Lynparza’s PROpel used investigators’ assessment of progression-free survival, while Zejula’s Magnitude used blinded central review.

[Bull78 @gideonpISR]

@StuckInStock It looks like the drug is causing the appearance of lesions...isn't it?

[Bull78 @gideonpISR]

@CaesarBiotech and...?